---
layout: post
title: "Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2023"
date: 2026-02-05 19:01:10 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-22638
original_published: 2022-10-18 00:00:00 +0000
significance: 8.00
---

# Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2023

**Published:** February 05, 2026 19:01 UTC
**Source:** Federal Register
**Original Published:** October 18, 2022 00:00 UTC
**Document Number:** 2022-22638

## Summary

The Drug Enforcement Administration (DEA) proposes to establish the 2023 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act (CSA) and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/10/18/2022-22638/proposed-aggregate-production-quotas-for-schedule-i-and-ii-controlled-substances-and-assessment-of)
- API: https://www.federalregister.gov/api/v1/documents/2022-22638

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
